SUTENT Side Effects

7007669-6 | Haemoptysis, Paraesthesia
on Sep 13, 2010 Male patient from UNITED STATES , weighting 142.0 lb, was diagnosed with metastatic renal cell carcinoma, coronary arterial stent insertion and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis, paraesthesia. Sutent dosage: 37.5 Mg, 1x/day, For 28 Days Every 42 Days. During the same period patient was treated with PLAVIX (Unk) (View Plavix Review and Plavix Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ).

7007623-4 |
Patient was taking Sutent (View Usage). on Sep 15, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 64 years of age, was diagnosed with renal cell carcinoma and. Sutent dosage: Unk.

7007555-1 | Headache, Hypertension
Adverse event was reported on Sep 15, 2010 by a Female patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day, Days 1 To 28) was diagnosed with renal cell carcinoma, hypertension, renal vein thrombosis, vena cava thrombosis and. Location: AUSTRALIA , 65 years of age, weighting 183.0 lb, After Sutent was administered, patient had the following side effects: headache (What is headache?), hypertension. During the same period patient was treated with ACCURETIC (12.5/20 1x/day) (View Accuretic Review and Accuretic Label ), ATENOLOL (50 Mg, 1x/day) (View Atenolol Review and Atenolol Label ), CLEXANE (View Clexane Review and Clexane Label ). Patient was hospitalized.

7006208-3 | Ageusia, Dysgeusia, Dyspepsia, Fatigue, Glossodynia, Sexual Dysfunction, Weight Decreased
on Sep 16, 2010 Male patient from UNITED STATES , weighting 153.0 lb, was diagnosed with renal cancer and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, dysgeusia, dyspepsia, fatigue, glossodynia, sexual dysfunction, weight decreased. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with TOPROL XL (Unk) (View Toprol-xl Review and Toprol-xl Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), FENOFIBRIC ACID (Unk) (View Fenofibric Acid Review and Fenofibric Acid Label ), OXYCODONE (Unk) (View Oxycodone Review and Oxycodone Label ), METHADONE (Unk) (View Methadone Review and Methadone Label ).


7006202-2 | Burning Sensation, Gait Disturbance, Glossodynia, Tooth Disorder
on Sep 03, 2010 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with lung neoplasm malignant and was treated with Sutent (View Usage). Patient had the following side effects: burning sensation, gait disturbance, glossodynia, tooth disorder (What is tooth disorder?). Sutent dosage: 50 Mg, 1x/day.

7006167-3 | Hepatotoxicity
Patient was taking Sutent (View Usage). After Sutent was administered, patient had the following side effects: hepatotoxicity on Sep 13, 2010 from PORTUGAL Additional patient health information: Male patient , 79 years of age, was diagnosed with renal cell carcinoma and. Sutent dosage: 50 Mg, 1x/day.

7006164-8 | Hypertriglyceridaemia
Adverse event was reported on Sep 10, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 28 Days On / 14 Days Off) was diagnosed with thyroid cancer (What is thyroid cancer?) and. Location: PORTUGAL , 55 years of age, weighting 240.3 lb, Patient experienced the following unwanted or unexpected effects: hypertriglyceridaemia.

7006147-8 | Hypothyroidism, Intestinal Obstruction
on Sep 13, 2010 Female patient from UNITED STATES , weighting 210.0 lb, was diagnosed with renal cancer metastatic, hypertension and was treated with Sutent (View Usage). Patient had the following side effects: hypothyroidism, intestinal obstruction. Sutent dosage: 12.5 Mg, 4x/day, 4 Weeks On And 2 Weeks Off.. During the same period patient was treated with ALENDRONIC ACID (70 Mg, 2x/day) (View Alendronic Acid Review and Alendronic Acid Label ), VALSARTAN (320 Mg, Daily) (View Valsartan Review and Valsartan Label ).

7006135-1 | Amnesia
on Sep 14, 2010 Male patient from INDIA , 25 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: amnesia. Sutent dosage: 37.5 Mg, 1x/day.

7006105-3 | Myositis, Palmar-plantar Erythrodysaesthesia Syndrome
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: myositis (What is myositis?), palmar-plantar erythrodysaesthesia syndrome on Sep 10, 2010 from BELGIUM Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with metastatic renal cell carcinoma and. Sutent dosage: 50 Mg, 4 Weeks On, 2 Weeks Off.

7006092-8 | Renal Failure
Adverse event was reported on Sep 14, 2010 by a Female patient taking Sutent (View Usage) (Dosage: Unk) was diagnosed with renal cancer and. Location: JAPAN , 70 years of age, Patient had the following side effects: renal failure. Patient was hospitalized.

7006091-6 | Transient Ischaemic Attack
on Sep 13, 2010 Female patient from UNITED STATES , weighting 164.9 lb, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: transient ischaemic attack. Sutent dosage: 37.5 Mg, 1x/day.

7006073-4 | Anaemia, Dyspnoea, Heart Valve Incompetence, Oedema Peripheral, Pneumonia, Swelling Face
on Sep 09, 2010 Female patient from UNITED STATES , weighting 194.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dyspnoea, heart valve incompetence, oedema peripheral, pneumonia (What is pneumonia?), swelling face. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with SYNTHROID (125 Mg, 1x/day) (View Synthroid Review and Synthroid Label ), GLYBURIDE (3 Mg, Unk) (View Glyburide Review and Glyburide Label ), QUINAPRIL (1 Tablet Daily) (View Quinapril Review and Quinapril Label ), ACTOS (Unk) (View Actos Review and Actos Label ), ALLOPURINOL (100 Mg, 2 Tablets Daily) (View Allopurinol Review and Allopurinol Label ), BENICAR (1 Tablet Daily) (View Benicar Review and Benicar Label ), HYDROCHLOROTHIAZIDE (25 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

7002653-0 | Blister, Blood Pressure Increased, Fatigue, Periorbital Oedema
Patient was taking Sutent (View Usage). Patient had the following side effects: blister, blood pressure increased, fatigue, periorbital oedema on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 72 years of age, was diagnosed with renal cancer, type 2 diabetes mellitus, splenectomy, blood cholesterol and. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), PHENOXYMETHYLPENICILLIN POTASSIUM (View Phenoxymethylpenicillin Potassium Review and Phenoxymethylpenicillin Potassium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).

7002648-7 | Face Oedema, Malaise
Adverse event was reported on Sep 09, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with renal cell carcinoma and. Location: JAPAN , 54 years of age, After Sutent was administered, patient had the following side effects: face oedema, malaise. During the same period patient was treated with NAUZELIN (View Nauzelin Review and Nauzelin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), DEPAS (View Depas Review and Depas Label ), LASIX (View Lasix Review and Lasix Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LOXONIN (View Loxonin Review and Loxonin Label ).

7002641-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Cheilitis, Decreased Appetite, Diarrhoea, Epistaxis, Neutrophil Count Decreased
on Sep 08, 2010 Female patient from JAPAN , 57 years of age, weighting 94.80 lb, was diagnosed with renal cell carcinoma, epilepsy (What is epilepsy?), hypertension, hyperuricaemia and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cheilitis, decreased appetite, diarrhoea, epistaxis, neutrophil count decreased. Sutent dosage: 37.5 Mg, 1x/day. During the same period patient was treated with DIAMOX SRC (125 Mg, 1x/day) (View Diamox Src Review and Diamox Src Label ), DEPAKENE (400 Mg, 2x/day) (View Depakene Review and Depakene Label ), AMLODIPINE (5 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ), ZYLORIC (100 Mg, 1x/day) (View Zyloric Review and Zyloric Label ). Patient was hospitalized.

7001684-4 | Metastases To Central Nervous System
on Sep 09, 2010 Female patient from GERMANY , 80 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). Patient had the following side effects: metastases to central nervous system. Sutent dosage: Unk. Patient was hospitalized.

7001670-4 |
Patient was taking Sutent (View Usage). on Sep 08, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 48 years of age, was diagnosed with renal cell carcinoma and. Sutent dosage: 50 Mg, 1x/day.

6994615-4 | Breast Cancer Metastatic, Delirium, Hypercalcaemia, Malignant Neoplasm Progression, Pyrexia
Adverse event was reported on Sep 16, 2010 by a Female patient taking Sutent (View Usage) (Dosage: 37.5mg Po) was diagnosed with metastases to central nervous system and. Location: UNITED STATES , 38 years of age, weighting 130.7 lb, Patient experienced the following unwanted or unexpected effects: breast cancer metastatic, delirium, hypercalcaemia, malignant neoplasm progression, pyrexia. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), PHENYTOIN SODIUM CAP (View Phenytoin Sodium Cap Review and Phenytoin Sodium Cap Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), COLACE (View Colace Review and Colace Label ), KADIAN (View Kadian Review and Kadian Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6992219-0 |
on Sep 06, 2010 Male patient from INDIA , 72 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent (View Usage). . Sutent dosage: 37.5 Mg, 1x/day.

6992216-5 | Disseminated Intravascular Coagulation, Hypothyroidism, Platelet Count Decreased, Renal Impairment, White Blood Cell Count Decreased
on Sep 08, 2010 Male patient from JAPAN , 65 years of age, weighting 143.3 lb, was diagnosed with renal cell carcinoma, hyperuricaemia, hypercholesterolaemia, constipation (What is constipation?), insomnia, reflux oesophagitis and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: disseminated intravascular coagulation, hypothyroidism, platelet count decreased, renal impairment, white blood cell count decreased. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with NEORAL (100 Mg, 2x/day) (View Neoral Review and Neoral Label ), PREDONINE (5 Mg, 1x/day) (View Predonine Review and Predonine Label ), URINORM (25 Mg, 1x/day) (View Urinorm Review and Urinorm Label ), FLUVASTATIN (60 Mg, 2x/day) (View Fluvastatin Review and Fluvastatin Label ), RHUBARB (1 G, 1x/day) (View Rhubarb Review and Rhubarb Label ), SENNOSIDE A (24 Mg, 1x/day) (View Sennoside A Review and Sennoside A Label ), LENDORMIN (0.25 Mg, 1x/day) (View Lendormin Review and Lendormin Label ), PARIET (10 Mg, 1x/day) (View Pariet Review and Pariet Label ).

6992006-3 | Epistaxis, Eye Haemorrhage, Hypertension, Intestinal Haemorrhage, Pyrexia
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, eye haemorrhage, hypertension, intestinal haemorrhage, pyrexia on Sep 07, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with renal cell carcinoma and. Sutent dosage: 50 Mg, 1x/day.

6992000-2 | Pleural Effusion
Adverse event was reported on Sep 07, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with renal cell carcinoma and. Location: JAPAN , 54 years of age, Patient had the following side effects: pleural effusion. Patient was hospitalized.

6991995-0 | Hypertriglyceridaemia
on Sep 07, 2010 Male patient from AUSTRALIA , weighting 278.9 lb, was diagnosed with renal cancer and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: hypertriglyceridaemia. Sutent dosage: 37.5 Mg, 1x/day. During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), CRESTOR (View Crestor Review and Crestor Label ).

6991847-6 | Bradycardia
on Sep 07, 2010 Female patient from JAPAN , 47 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia. Sutent dosage: .

6988531-1 | Amnesia, Blood Pressure Increased, Dyspnoea, Headache, Hyperhidrosis, Hypokalaemic Syndrome, Muscular Weakness, Palmar-plantar Erythrodysaesthesia Syndrome, Tongue Disorder
Patient was taking Sutent (View Usage). Patient had the following side effects: amnesia, blood pressure increased, dyspnoea, headache (What is headache?), hyperhidrosis, hypokalaemic syndrome, muscular weakness, palmar-plantar erythrodysaesthesia syndrome, tongue disorder on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with neoplasm malignant and. Sutent dosage: 50 Mg, 1x/day, For 28 Days Evey 42 Days. Patient was hospitalized.

6988522-0 | Abdominal Discomfort, Blood Calcium Decreased, Diarrhoea, Gastrointestinal Toxicity, Mouth Ulceration, Oral Pain, Weight Decreased
Adverse event was reported on Sep 07, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with renal cancer, arthritis (What is arthritis?), adenomatous polyposis coli, hypertension and. Location: UNITED STATES , weighting 144.0 lb, After Sutent was administered, patient had the following side effects: abdominal discomfort, blood calcium decreased, diarrhoea, gastrointestinal toxicity, mouth ulceration, oral pain, weight decreased. During the same period patient was treated with CELEBREX (100 Mg, As Needed) (View Celebrex Review and Celebrex Label ), PERCOCET (Daily) (View Percocet Review and Percocet Label ), VISTARIL (20 Mg, 1x/day) (View Vistaril Review and Vistaril Label ), ZESTRIL (View Zestril Review and Zestril Label ).

6988520-7 | Hypokalaemia
on Sep 06, 2010 Male patient from GERMANY , 72 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with ASPIRIN (100 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), ISOSORBIDE MONONITRATE (Unk) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), CALCIUM CARBONATE/COLECALCIFEROL (500 Mg, 1x/day) (View Calcium Carbonate/colecalciferol Review and Calcium Carbonate/colecalciferol Label ), METHOTREXATE (15 Mg, Weekly) (View Methotrexate Review and Methotrexate Label ), FOLINIC ACID (5 Mg, Two Times Per Week) (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

6987549-2 | Ageusia, Fatigue, Sexual Dysfunction, Weight Decreased
on Sep 10, 2010 Male patient from UNITED STATES , weighting 153.0 lb, was diagnosed with renal cancer and was treated with Sutent (View Usage). Patient had the following side effects: ageusia, fatigue, sexual dysfunction, weight decreased. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with TOPROL XL (Unk) (View Toprol-xl Review and Toprol-xl Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), FENOFIBRIC ACID (Unk) (View Fenofibric Acid Review and Fenofibric Acid Label ), OXYCODONE (Unk) (View Oxycodone Review and Oxycodone Label ), METHADONE (Unk) (View Methadone Review and Methadone Label ).

6987216-5 | Anaphylactic Reaction, Lip Swelling, Local Swelling, Oedema Mucosal
Patient was taking Sutent (View Usage). After Sutent was administered, patient had the following side effects: anaphylactic reaction, lip swelling, local swelling, oedema mucosal on Sep 07, 2010 from GERMANY Additional patient health information: Male patient , 36 years of age, was diagnosed with metastatic renal cell carcinoma and. Sutent dosage: 50 Mg, Unk. Patient was hospitalized.

6987182-2 | Conjunctivitis, Glossitis, Lip Ulceration
Adverse event was reported on Sep 07, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with thymoma, spinal disorder and. Location: FRANCE , 52 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: conjunctivitis, glossitis, lip ulceration. During the same period patient was treated with MEDROL (32 No Unit Provided, 1x/day) (View Medrol Review and Medrol Label ).

6987175-5 | Gout
on Sep 07, 2010 Female patient from UNITED STATES , weighting 244.9 lb, was diagnosed with renal cancer, gout (What is gout?), inflammation, hypertension, glucose tolerance impaired and was treated with Sutent (View Usage). Patient had the following side effects: gout (What is gout?). Sutent dosage: 25 Mg, Every Other Day. During the same period patient was treated with ALLOPURINOL (100 Mg, 2x/day) (View Allopurinol Review and Allopurinol Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), ACEBUTOLOL (600 Mg, Unk) (View Acebutolol Review and Acebutolol Label ), SITAGLIPTIN (100 Mg, Unk) (View Sitagliptin Review and Sitagliptin Label ).

6985329-5 | Gingival Bleeding, Toothache, Vulvovaginal Pruritus
on Aug 11, 2010 Female patient from UNITED STATES , weighting 291.0 lb, was diagnosed with renal cell carcinoma, blood cholesterol, blood pressure (What is blood pressure?), thyroid disorder, restless legs syndrome, diabetes mellitus and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: gingival bleeding, toothache, vulvovaginal pruritus. Sutent dosage: . During the same period patient was treated with LIPITOR (10 Mg, Daily) (View Lipitor Review and Lipitor Label ), METOPROLOL (25 Mg, Daily) (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (10/12.5mg, Daily) (View Lisinopril Review and Lisinopril Label ), LEVOTHYROXINE (0.75 Mg, Daily) (View Levothyroxine Review and Levothyroxine Label ), CARBIDOPA AND LEVODOPA (25/100 Mg, Daily) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), METFORMIN (500 Mg, 2x/day) (View Metformin Review and Metformin Label ).

6984849-7 | Aortic Dilatation, Hypertension
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dilatation, hypertension on Sep 07, 2010 from BELGIUM Additional patient health information: Male patient , 58 years of age, was diagnosed with renal cell carcinoma and. Sutent dosage: .

6984612-7 | Acute Pulmonary Oedema, Cardiac Failure Acute
Adverse event was reported on Sep 03, 2010 by a Female patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with neuroendocrine carcinoma, prophylaxis against gastrointestinal ulcer and. Location: SPAIN , 53 years of age, Patient had the following side effects: acute pulmonary oedema, cardiac failure acute. During the same period patient was treated with OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6984567-5 | Hepatitis
on Sep 03, 2010 Female patient from SPAIN , 43 years of age, weighting 147.7 lb, was diagnosed with thyroid cancer (What is thyroid cancer?), pain (What is pain?) and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: hepatitis (What is hepatitis?). Sutent dosage: 37.5 Mg, 1x/day. During the same period patient was treated with IBUPROFEN (Unk) (View Ibuprofen Review and Ibuprofen Label ).

6984554-7 | Anaemia Of Malignant Disease, Deep Vein Thrombosis, Haematoma, Haemorrhage, Haemorrhagic Anaemia, Herpes Virus Infection, Leukopenia, Oral Herpes, Pulmonary Embolism
on Sep 03, 2010 Female patient from AUSTRIA , 70 years of age, weighting 165.3 lb, was diagnosed with renal cell carcinoma, paresis and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia of malignant disease, deep vein thrombosis (What is deep vein thrombosis?), haematoma, haemorrhage, haemorrhagic anaemia, herpes virus infection, leukopenia, oral herpes, pulmonary embolism (What is pulmonary embolism?). Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with FORTECORTIN (8 Mg, 3x1) (View Fortecortin Review and Fortecortin Label ).

6984537-7 | Arrhythmia, Cerebral Infarction
Patient was taking Sutent (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), cerebral infarction on Sep 06, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 112.4 lb, was diagnosed with renal cell carcinoma and. Sutent dosage: 12.5 Mg, 4x/day. During the same period patient was treated with LOXONIN (60 Mg, 3x/day) (View Loxonin Review and Loxonin Label ), FAMOTIDINE (10 Mg, 2x/day) (View Famotidine Review and Famotidine Label ).

6981205-2 | Hyperthyroidism
Adverse event was reported on Sep 03, 2010 by a Male patient taking Sutent (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with renal cancer and. Location: UNITED STATES , weighting 164.0 lb, After Sutent was administered, patient had the following side effects: hyperthyroidism. Patient was hospitalized.

6980052-5 | Scar
on Sep 02, 2010 Male patient from FRANCE , 58 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: scar (What is scar?). Sutent dosage: .

6976391-4 | Chromaturia
on Sep 02, 2010 Female patient from UNITED STATES , weighting 205.0 lb, was diagnosed with metastatic renal cell carcinoma, hypertension, blood cholesterol abnormal, thyroid disorder and was treated with Sutent (View Usage). Patient had the following side effects: chromaturia. Sutent dosage: 25 Mg, 1x/day, 4 Weeks On And 2 Weeks Off. During the same period patient was treated with BENICAR (12.4 Mg, 1x/day) (View Benicar Review and Benicar Label ), ACETYLSALICYLIC ACID (325 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SYNTHROID (0.05 Mg, 1x/day) (View Synthroid Review and Synthroid Label ).

6976102-2 | Hypoaesthesia
Patient was taking Sutent (View Usage). After Sutent was administered, patient had the following side effects: hypoaesthesia on Sep 01, 2010 from CANADA Additional patient health information: Male patient , 78 years of age, weighting 165.3 lb, was diagnosed with gastrointestinal stromal tumour and. Sutent dosage: 25 Mg, 1x/day. During the same period patient was treated with FLEXERIL (Unk) (View Flexeril Review and Flexeril Label ), PROSCAR (Unk) (View Proscar Review and Proscar Label ), ALFUZOSIN HCL (Unk) (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), FOSAMAX (Unk) (View Fosamax Review and Fosamax Label ), PANTOLOC ^NYCOMED^ (Unk) (View Pantoloc ^nycomed^ Review and Pantoloc ^nycomed^ Label ), SENNA (Unk) (View Senna Review and Senna Label ), DOCUSATE (Unk) (View Docusate Review and Docusate Label ), CALCITE D (Unk) (View Calcite D Review and Calcite D Label ).

6973038-8 |
Adverse event was reported on Aug 30, 2010 by a Male patient taking Sutent (View Usage) (Dosage: '1#qd') was diagnosed with renal cell carcinoma and. Location: TAIWAN, PROVINCE OF CHINA , 72 years of age, .

6972723-1 |
on Aug 31, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 85 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). . Sutent dosage: .

6971115-9 |
on Aug 25, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 81 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent (View Usage). . Sutent dosage: 3q, 1x/day.

6970974-3 | Palmar-plantar Erythrodysaesthesia Syndrome, Skin Ulcer
Patient was taking Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: palmar-plantar erythrodysaesthesia syndrome, skin ulcer on Aug 27, 2010 from GERMANY Additional patient health information: Male patient , weighting 172.0 lb, was diagnosed with metastatic renal cell carcinoma and. Sutent dosage: 50 Mg, 1x/day, 4 Weeks On, 2 Weeks Off. During the same period patient was treated with SIMVASTATIN (20 Mg, 1x/day) (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (5 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ), ENABETA (10 Mg/25 Mg, 1x/day) (View Enabeta Review and Enabeta Label ), ALLOPURINOL (300 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ).

6970913-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Cheilitis, Decreased Appetite, Diarrhoea, Epistaxis, Neutrophil Count Decreased
Adverse event was reported on Aug 30, 2010 by a Female patient taking Sutent (View Usage) (Dosage: 37.5 Mg, 1x/day) was diagnosed with renal cell carcinoma, epilepsy (What is epilepsy?), hypertension, hyperuricaemia and. Location: JAPAN , 57 years of age, weighting 94.80 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cheilitis, decreased appetite, diarrhoea, epistaxis, neutrophil count decreased. During the same period patient was treated with DIAMOX SRC (125 Mg, 1x/day) (View Diamox Src Review and Diamox Src Label ), DEPAKENE (400 Mg, 2x/day) (View Depakene Review and Depakene Label ), AMLODIPINE (5 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ), ZYLORIC (100 Mg, 1x/day) (View Zyloric Review and Zyloric Label ). Patient was hospitalized.

6970645-3 | Burning Sensation, Gait Disturbance, Glossodynia, Tooth Disorder
on Sep 03, 2010 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with lung disorder and was treated with Sutent (View Usage). After Sutent was administered, patient had the following side effects: burning sensation, gait disturbance, glossodynia, tooth disorder (What is tooth disorder?). Sutent dosage: 50 Mg, Daily.

6968928-6 | Deep Vein Thrombosis, Myalgia
on Aug 27, 2010 Female patient from UNITED STATES , weighting 121.9 lb, was diagnosed with lung neoplasm, myalgia, hypertension, prophylaxis and was treated with Sutent (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), myalgia. Sutent dosage: 50 Mg, 1x/day. During the same period patient was treated with ALEVE (CAPLET) (200 Mg, Unk) (View Aleve (caplet) Review and Aleve (caplet) Label ), CLONIDINE (0.2 Mg, 1x/day) (View Clonidine Review and Clonidine Label ), METOPROLOL (100 Mg, 1x/day) (View Metoprolol Review and Metoprolol Label ), LOSARTAN (75 Mg, 1x/day) (View Losartan Review and Losartan Label ), AMLODIPINE (10 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ), HYDROCHLOROTHIAZIDE (25 Mg, 1x/day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ACETYLSALICYLIC ACID (81 Mg, Alternate Day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CALCIUM WITH VITAMIN D (600 Mg, 2x/day) (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ).

6968668-3 | Chromaturia, Contusion, Diarrhoea, Dizziness, Dyspnoea, Fatigue, Fungal Infection, Glossodynia, Hyperhidrosis
Patient was taking Sutent (View Usage). Patient had the following side effects: chromaturia, contusion, diarrhoea, dizziness (What is dizziness?), dyspnoea, fatigue, fungal infection (What is fungal infection?), glossodynia, hyperhidrosis on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 259.9 lb, was diagnosed with phaeochromocytoma, hypertension and. Sutent dosage: 50 Mg, Unk. During the same period patient was treated with LASIX (40 Mg, As Needed) (View Lasix Review and Lasix Label ), DIBENZYLINE (10 Mg, Unk) (View Dibenzyline Review and Dibenzyline Label ).